Published in Am J Hosp Palliat Care on May 10, 2013
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage (2007) 3.69
Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q (2011) 2.09
Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer. J Clin Oncol (2010) 1.81
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Medicare cost in matched hospice and non-hospice cohorts. J Pain Symptom Manage (2004) 1.65
Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol (2003) 1.46
Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma. Dis Manag (2006) 1.06
The effect of hospice on Medicare and informal care costs: the U.S. Experience. J Pain Symptom Manage (2009) 0.89
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Cachexia: a new definition. Clin Nutr (2008) 5.49
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol (2008) 3.15
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol (2003) 2.32
Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers. Support Care Cancer (2015) 2.11
Preoperative testing before noncardiac surgery: guidelines and recommendations. Am Fam Physician (2013) 2.07
Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol (2008) 2.05
Current management strategies for ovarian cancer. Mayo Clin Proc (2007) 1.94
Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol (2012) 1.74
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol (2004) 1.66
Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med (2011) 1.57
Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg (2009) 1.51
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. J Thorac Oncol (2012) 1.51
Symptom control trials: a 20-year experience. J Support Oncol (2007) 1.48
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer (2008) 1.23
The positive impact of a facilitated peer mentoring program on academic skills of women faculty. BMC Med Educ (2012) 1.17
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer (2014) 1.15
Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep (2008) 1.12
Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist (2009) 1.08
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Anticancer Drugs (2013) 1.04
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Cancer Chemother Pharmacol (2006) 1.01
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys (2007) 1.01
Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer (2009) 0.99
Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer (2005) 0.98
Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep (2010) 0.97
The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage (2011) 0.96
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer (2007) 0.96
End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference? Oncology (2011) 0.95
Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage (2011) 0.94
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer (2005) 0.92
The cancer anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep (2005) 0.92
Non–small-cell lung cancer in elderly patients: a discussion of treatment options. J Clin Oncol (2014) 0.91
Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. J Thorac Oncol (2015) 0.89
Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series. Case Rep Oncol (2013) 0.89
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther (2008) 0.88
Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol (2006) 0.87
Should we recommend surgery to patients with limited small cell carcinoma of the esophagus? J Thorac Oncol (2008) 0.87
New agents, new rashes: an update on skin complications from cancer chemotherapy. Curr Oncol Rep (2006) 0.86
Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer (2012) 0.85
What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med (2010) 0.84
Patients' rationale for declining participation in a cancer-associated weight loss study. J Cachexia Sarcopenia Muscle (2014) 0.84
A systematic compilation of reports published on opioid-related problems. J Opioid Manag (2011) 0.84
Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol (2013) 0.84
E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication. J Palliat Med (2010) 0.83
An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer. J Gastrointest Cancer (2009) 0.82
Spinal intradural extraosseous Ewing's sarcoma. Rare Tumors (2011) 0.82
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer (2004) 0.82
Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer? J Support Oncol (2006) 0.82
Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer (2009) 0.82
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology (2008) 0.81
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol (2011) 0.81
Cancer diagnoses in Iraqi refugees. Acta Oncol (2012) 0.81
The feasibility and educational value of Hear My Voice, a chaplain-led spiritual life review process for patients with brain cancers and progressive neurologic conditions. J Cancer Educ (2015) 0.81
Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology. BMC Cancer (2013) 0.81
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature. J Cancer Educ (2013) 0.81
Adenosine triphosphate: does it help cancer patients "get bigger and stronger"? J Clin Oncol (2002) 0.81
The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer (2015) 0.80
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag (2008) 0.80
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer (2011) 0.80
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci (2010) 0.80
STEPP for the EGFR inhibitor-induced rash--definitely a step in the right direction. Curr Oncol Rep (2010) 0.79
Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial. Support Cancer Ther (2007) 0.79
Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol (2004) 0.79
The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem (2004) 0.78
Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology (2011) 0.78
Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav (2008) 0.78
An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer. Support Care Cancer (2011) 0.78
Parenteral nutrition in patients with cancer: recent guidelines and a need for further study. Curr Opin Support Palliat Care (2010) 0.78
Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med (2011) 0.78
Wine for appetite loss: "how do you know?". J Clin Oncol (2007) 0.77
If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Educ (2009) 0.77
The association between recent abuse and menopausal symptom bother: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS). Menopause (2016) 0.77
Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment. J Cancer Educ (2011) 0.77
Osseous metastases: drugs that enhance bone integrity and prevent adverse skeletal events. Expert Opin Pharmacother (2009) 0.77
Who is counseled to lose weight? Survey results and anthropometric data from 3,149 lower socioeconomic women. J Community Health (2012) 0.77
Pharmacological options for advanced cancer patients with loss of appetite and weight. Expert Opin Pharmacother (2007) 0.77
Pain and other symptom severity in women with fibromyalgia and a previous hysterectomy. J Pain Res (2011) 0.76
Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ (2007) 0.76
Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival. J Geriatr Oncol (2013) 0.76
Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials. J Palliat Med (2011) 0.76
Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis (2011) 0.76
Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr (2006) 0.76
Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy. J Cancer Educ (2010) 0.76
Adjuvant chemotherapy in colon cancer: ageism or appropriate care? J Clin Oncol (2011) 0.76
Former military officers from the Republic of Vietnam now living in the united states (US): exploring their perceptions of the US healthcare system. J Community Health (2011) 0.75
Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E. Clin Med Oncol (2008) 0.75
A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors. Psychooncology (2010) 0.75
Causes and palliation of transfusion-associated vaginal bleeding in patients with metastatic cancer. Int J Gynecol Cancer (2014) 0.75
Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care. J Palliat Med (2009) 0.75
Wanted--and Needed--more studies in geriatric lung cancer patients. J Thorac Oncol (2007) 0.75
Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer (2014) 0.75
Practical strategies to circumvent and/or surmount six barriers in health disparities research: observations from a pilot project among Vietnamese Americans. J Cancer Educ (2011) 0.75
Rash from newer cancer agents: why do we still not have effective therapy for palliation and/or prevention? J Support Oncol (2010) 0.75
Response. Support Care Cancer (2015) 0.75
Asphyxiation with a fentanyl patch. Case Rep Oncol (2013) 0.75
Who should receive parenteral nutrition or pharmacologic therapy for loss of appetite and weight in the setting of incurable cancer? Curr Opin Support Palliat Care (2007) 0.75
Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol (2010) 0.75